Page results
-
UCLH vision, values and strategy
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
Patient information on managing pain
-
Health and wellbeing information for people affected by cancer.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
File results
-
FOI/2023/0359 - Medicines management/ prescribing/ formulary committees at Trust
-
FOI/2023/0358 - Diagnosis of POTS syndrome (postural orthostatic tachycardia syndrome (PoTS))
-
FOI/2023/0356 - Current wait time for referral to treatment with a consultant for osteoporosis
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases